Biolab has recently introduced the state-of-the-art technology in vascular access, the VeinViewer, in an effort to minimize the levels of stress, anxiety and discomfort that accompany patients and their families when drawing blood.
The VeinViewer enables Biolab medical phlebotomists to clearly see and locate the veins up to 10mm below the surface of the skin in real time, providing a visual roadmap to patients’ vessels. This technology is especially ideal for children, elderly and overweight patients; and is currently available at biolab at no extra cost.
“We are committed to providing the latest in medical testing,’ elaborates Dr. Amid Abdelnour, Biolab CEO. “ and in line with our slogan ‘where health matters’, we have introduced this technology to provide our patients with a new lab experience free of anxiety and discomfort.
Developed by Christie Medical Holdings, Inc., the device utilizes harmless near-infrared light, a digital video camera and an image processing unit to build an image of the patient’s vasculature in real-time and directly onto the surface of the skin regardless of age, body type or skin tone.
“This technology is changing the standard of compassionate care. We truly believe it will become a new standard of care throughout the world,” said Chris Schnee, general manager for Christie Medical Innovations. “And we’re thrilled that Biolab is joining the ranks of multiple premier health care facilities nationwide that have adopted the VeinViewer technology.”
Upon introducing this technology, Biolab has joined the ranks of premier health care institutions investing in this technology, including M. D. Anderson in Houston, Duke University Health System in North Carolina, New York-based Winthrop Medical Center, Cleveland Clinic, Massachusetts General and John Hopkins Hospital, in addition to several military and government facilities.